【BIOSIS 7193 交流专区】 生物科学

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30/09/2013

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30/09/2013	30/09/2012	30/09/2013	30/09/2012
		$$'000	$$'000	$$'000	$$'000

1	Revenue	1,792	4,546	3,395	9,482
2	Profit/(loss) before tax	-6,030	-1,560	-9,639	-3,186
3	Profit/(loss) for the period	-6,030	-1,563	-9,639	-3,191
4	Profit/(loss) attributable to ordinary equity holders of the parent	-5,239	-1,247	-8,848	-2,684
5	Basic earnings/(loss) per share (Subunit)	-4.99	-1.19	-8.43	-2.56
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0200		0.1300

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/12/2013

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/12/2013	31/12/2012	31/12/2013	31/12/2012
		$$'000	$$'000	$$'000	$$'000

1	Revenue	2,809	3,951	6,204	13,433
2	Profit/(loss) before tax	-18,611	-713	-28,250	-3,899
3	Profit/(loss) for the period	-17,888	-715	-27,527	-3,906
4	Profit/(loss) attributable to ordinary equity holders of the parent	-17,371	-511	-26,219	-3,195
5	Basic earnings/(loss) per share (Subunit)	-16.54	-0.49	-24.97	-3.04
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	-0.1500		0.1300

icy97

Notice of Person Ceasing (29C)

BIOSIS GROUP BERHAD

Particulars of substantial Securities Holder

Name	ZULKIFLI BIN OSMAN
Address	No. 7-2, Jalan 2/149B Gateway Avenue Bandar Sri Petaling 57000 Kuala Lumpur
NRIC/Passport No/Company No.	600218-07-5769
Nationality/Country of incorporation	Malaysian
Descriptions (Class & nominal value)	Ordinary shares of RM0.50 each
Date of cessation	21/05/2014
Name & address of registered holder	Zulkifli Bin Osman No. 7-2, Jalan 2/149B Gateway Avenue Bandar Sri Petaling 57000 Kuala Lumpur
Currency	Malaysian Ringgit (MYR)
Number of securities disposed	15,502,800
Price Transacted ($$)
Circumstances by reason of which a person ceases to be a substantial securities Holder	Open Market
Nature of interest	Direct
Date of notice	26/05/2014

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/03/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/03/2014	31/03/2013	31/03/2014	31/03/2013
		$$'000	$$'000	$$'000	$$'000

1	Revenue	3,294	330	9,499	13,081
2	Profit/(loss) before tax	-9,815	-12,339	-38,065	-17,188
3	Profit/(loss) for the period	-9,615	-12,389	-37,141	-16,809
4	Profit/(loss) attributable to ordinary equity holders of the parent	-8,312	-12,245	-34,531	-15,727
5	Basic earnings/(loss) per share (Subunit)	-6.69	-11.66	-32.91	-14.91
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	-0.2200		0.1300

APULA

面值減45仙至5仙 保優生削資配股重組
財經股市6 Jun 2014 21:00
http://www.chinapress.com.my/node/532839

（吉隆坡6日訊）因審計師質疑未來營運能力，而遭馬證交所列為PN17公司的保優生（BIOSIS，7193，主要板消費股），建議重組計劃，包括資本削減、股票整合、私下配售，以及附加股送憑單議案。

保優生向馬證交所報備，建議資本削減，將股票面值從50仙，削減45仙至5仙，以降低累積虧損。

該公司也建議，屆時將2股面值5仙的股，整合成為1股10仙面值。

除了資本削減和股票整合，該公司建議，為特定投資者發售每股發售價10仙，約1億5000萬新股。

根據報備文件，該公司預計透過私下配售可籌集1500萬令吉。其中該公司計劃動用1300萬令吉作為營運資本，剩余200萬令吉將支付重組計劃的開銷。

該公司計劃，隨后每持1股現有股的股東，將可認購1股附加股，發售高達4億4250萬附加股。

該公司也以每持1股附加股，配送1憑單比例，發送高達 4億4250萬免費憑單。

Type	Announcement
Subject	PRACTICE NOTE 17 / GUIDANCE NOTE 3 REGULARISATION PLAN
Description	BIOSIS GROUP BERHAD (“BGB” OR THE “COMPANY”) •        PROPOSED CAPITAL REDUCTION AND CONSOLIDATION; •        PROPOSED PRIVATE PLACEMENT; •        PROPOSED SCHEMES OF ARRANGEMENT WITH CREDITORS; •        PROPOSED RIGHTS ISSUE WITH WARRANTS; •        PROPOSED EXEMPTION; AND •        PROPOSED AMENDMENT
Reference is made to the Company’s announcement dated 26 June 2013, wherein it was announced that BGB has been classified as an affected listed issuer under Paragraph 2.1(e) of the Practice Note No. 17 of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad. In relation thereto, BGB proposes to implement the following: (i) Proposed Capital Reduction and Consolidation; (ii) Proposed Private Placement; (iii) Proposed Schemes of Arrangement with Creditors; (iv) Proposed Rights Issue with Warrants; (v) Proposed Exemption; and (vi) Proposed Amendment (collectively known as the “Proposed Regularisation Plan”). Further details of the Proposed Regularisation Plan are set out in the attachment. This announcement is dated 6 June 2014. http://www.bursamalaysia.com/market/listed-companies/company-announcements/1650201

Attachments BGB Final-Proposed Regularisation Plan.pdf

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	BIO OSMO BERHAD (“BIO OSMO” OR THE “COMPANY”) PRIVATE PLACEMENT
For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcement dated 4 March 2014 in relation to the Private Placement. We refer to the Company’s announcement dated 4 March 2014 and its previous announcements in relation to the Private Placement.    On behalf of the Board of Directors of Bio Osmo, KAF Investment Bank Berhad is pleased to announce that the Company has fixed the issue price for the second tranche of the Private Placement comprising 11,800,000 Placement Shares at RM0.20 per Placement Share. The said issue price of RM0.20 per Placement Share represents a premium of approximately 38.50% from the five (5)-day volume weighted average market traded price of Bio Osmo Shares up to and including 13 June 2014 of approximately RM0.1444 per Bio Osmo Share. This announcement is dated 16 June 2014.

icy97

生物科学净利误差624万

财经新闻 财经  2014-08-13 11:31
（吉隆坡12日讯）生物科学（BIOSIS，7193，主板消费产品股）截至3月31日财年，已审计净利为4079万6000令吉，较未审计的3455万5000令吉，相差624万1000令吉，或18.06%。

根据文告，这是因为货物过境时被误取影响营收、错误记录资产重估价值以及少算罚息。【南洋网财经】

BIOSIS GROUP BERHAD

Type	Announcement
Subject	OTHERS
Description	BIOSIS GROUP BERHAD (“BIOSIS” OR THE “COMPANY”) DEVIATION BETWEEN THE UNAUDITED AND AUDITED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED (“FYE”) 31 MARCH 2014
Pursuant to Paragraph 9.19 (35) of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of BIOSIS wishes to inform that the loss-after-tax and minority interest for the FYE 31 March 2014 ("LATMI") of BIOSIS and its subsidiaries (“BIOSIS Group”) of approximately RM34.56 million as stated in the unaudited financial statements of BIOSIS Group has deviated by approximately 18% to the LATMI of approximately RM40.80 million as stated in the annual audited accounts of BIOSIS Group for the FYE 31 March 2014. An explanation of the deviation and reconciliation thereof are contained in the attached file. This announcement is dated 11 August 2014. http://www.bursamalaysia.com/market/listed-companies/company-announcements/1706721

Attachments Biosis.2014 Variance.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30/06/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30/06/2014	30/06/2013	30/06/2014	30/06/2013
		$$'000	$$'000	$$'000	$$'000

1	Revenue	4,046	1,603	4,046	1,603
2	Profit/(loss) before tax	247	-3,609	247	-3,609
3	Profit/(loss) for the period	234	-3,609	234	-3,609
4	Profit/(loss) attributable to ordinary equity holders of the parent	354	-3,239	354	-3,239
5	Basic earnings/(loss) per share (Subunit)	0.34	-3.08	0.34	-3.08
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	-0.2400		-0.2400

icy97

Type	Announcement
Subject	OTHERS
Description	BIOSIS GROUP BERHAD (“BIOSIS” OR “COMPANY”) DISPOSAL OF ENTIRE EQUITY INTEREST IN PT INDOBIOSIS MARKETING, BIOSIS MARKETING (SIN) PTE LTD, BIOSIS MARKETING (BD) LTD AND BIOSIS MARKETING CORPORATION LIMITED (ANNOUNCEMENT PURSUANT TO PARAGRAPH 9.19(24) OF MAIN MARKET LISTING REQUIREMENTS)
The Board of Directors of the Company wishes to announce that Biosis Marketing Sdn Bhd (“BMSB”), a wholly-owned subsidiary of Biosis, had on 25 September 2014 entered into Sale and Purchase Agreements (“SPA”) with Chan Kwong Choy in relation to the Proposed Disposal. Please refer to the attachment for further details on the Proposed Disposal. This announcement is dated 26 September 2014. http://www.bursamalaysia.com/market/listed-companies/company-announcements/1750297

Attachments Announcemt Sale of Foreign Subsidiaries.pdf

icy97

Type	Announcement
Subject	PRACTICE NOTE 17 / GUIDANCE NOTE 3 REGULARISATION PLAN
Description	BIOSIS GROUP BERHAD ("BGB" OR the "COMPANY") - PROPOSED REVISED REGULARISATION PLAN PURSUANT TO PN17 OF THE LISTING REQUIREMENTS
We refer to the announcement dated 6 June 2014 in relation to the proposed regularisation plan of BGB to regularise its financial condition, which comprises the following:- (i) Proposed Capital Reduction and Consolidation; (ii) Proposed Private Placement; (iii) Proposed Schemes of Arrangement with Creditors; (iv) Proposed Rights Issue with Warrants; (v)  Proposed Exemption; and (vi) Proposed Amendment (collectively, referred to as the “Proposed Regularisation Plan”) However, due to further discussions with potential investors interested to subscribe for the placement shares pursuant to the proposed private placement, confirmation on the two interested directors who are subscribing for the placement shares, negotiations with creditors, updates/checking of the outstanding amount owing to the creditors, and changes in the utilisation of proceeds raised, certain changes to the Proposed Regularisation Plan have been made. Unless otherwise defined, the abbreviations and definitions used in this announcement of the Company dated 29 September 2014 in relation to the proposed revised regularisation plan shall apply hereinafter. Summary of the main changes proposed to be made to the Proposed Regularisation Plan are as follows:- The proposed consolidation has been aborted. In view of this change, the par value of the BGB shares after the proposed capital reduction remains at RM 0.05 per BGB share. Accordingly, the number of shares to be issued pursuant to the original proposed schemes of arrangement, proposed rights issue with warrants will differ. Certain additional terms and conditions have been added into the proposed scheme of arrangement with the creditors which includes the treatment of unsecured creditors with outstanding amount as at 31 December 2013 of RM10,000 or below, essential creditors and the new inclusion of the settlement of ordinary shares in BPSB held by Crystal Anthem Sdn Bhd amounting to 1 million shares of RM1.00 each in BPSB via the exchange of 10,000,000 new BGB shares of RM 0.05 each. Changes have been made to the utilisation of proceeds arising from the Proposed Private Placement and Proposed Rights Issue with Warrants. The investors subscribing the Placement Shares pursuant to the Proposed Private Placement and Proposed Allocations have been identified. The investors include CPE, Encik Shahfie Bin Ahmad and Encik Khairul Azwan Bin Harun (who are both directors of BGB). There are a total of three (3) such investors, each subscribing the Placement Shares on a proportionate basis. The basis for the free Warrants attached to the Rights Shares has been amended to ensure compliance with Paragraph 6.50 of the MMLR under the Maximum Scenario. A proposed increase in authorised share capital has been added to facilitate the proposed capital reduction, proposed private placement, proposed schemes of arrangement and proposed rights issue with warrants. Based on the above, the Proposed Regularisation Plan has been revised to be as follows; Proposed Capital Reduction; Proposed Private Placement; Proposed Allocations; Proposed Schemes of Arrangement; Proposed Rights Issue with Warrants; Proposed Increase in Authorised Share Capital; and Proposed Amendment. The abovementioned revised proposals shall collectively be referred to as the “Proposed Revised Regularisation Plan”. On behalf of  BGB, SJ Securities wishes to announce the Proposed Revised Regularisation Plan, the details of which are provided in the attachment. This announcement is dated 29 September 2014. http://www.bursamalaysia.com/market/listed-companies/company-announcements/1751593

Attachments Biosis Group Berhad (revised announcement).pdf

icy97

Notice of Interest Sub. S-hldr (29A)

BIOSIS GROUP BERHAD

Particulars of Substantial Securities Holder

Name	Erwan Dato' Azizi
Address	No. 46 Jalan Satu Taman TAR Ampang 68000 Kuala Lumpur
NRIC/Passport No/Company No.	821212-14-5681
Nationality/Country of incorporation	Malaysian
Descriptions (Class & nominal value)	Ordinary shares of RM0.50 each
Name & address of registered holder	Erwan Dato' Azizi No. 46 Jalan Satu Taman TAR Ampang 68000 Kuala Lumpur

Date interest acquired & no of securities acquired
Currency	Malaysian Ringgit (MYR)
Date interest acquired	01/10/2014
No of securities	10,208,700
Circumstances by reason of which Securities Holder has interest	Off market transaction
Nature of interest	Direct
Price Transacted ($$)
Total no of securities after change
Direct (units)	20,000,000
Direct (%)	19.05
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Date of notice	02/10/2014

APULA

阿茲茲場外購19.05%‧成保優生最大單一股東
2014-10-04 10:52
http://biz.sinchew.com.my/node/103118?tid=6

（吉隆坡3日訊）PN17公司保優生（BIOSIS,7193,主板消費品組）迎來新大股東，拿督阿茲茲在場外收購1千零20萬8千700股股票後，以2千萬股或19.05%股權崛起成最大單一股東。

不過，交易所資料並未透露上述股權交易價格和賣家身份。

保優生是因股東基金低於繳足資本的50%，加上稽查師憂慮公司持續營運能力，而在去年6月被交易所列為PN17公司；截至上週五，保優生最後掛價為13仙，無交易。（星洲日報／財經）

icy97

Date of change	14/11/2014
Name	ERWAN BIN DATO’ AZIZI
Age	31
Nationality	Malaysian
Type of change	Appointment
Designation	Director
Directorate	Non Independent & Non Executive
Qualifications	Bachelor Degree in International Business & Finance, Regents School, London, UK
Working experience and occupation	Encik Erwan Dato' Azizi has diversified interests ranging from construction and property development and serves as director of several other private companies.
Directorship of public companies (if any)	Nil
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	20,000,000 ordinary shares of RM0.50 each in Biosis Group Berhad

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30/09/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30/09/2014	30/09/2013	30/09/2014	30/09/2013
		$$'000	$$'000	$$'000	$$'000

1	Revenue	2,238	1,792	6,284	3,395
2	Profit/(loss) before tax	209	-6,030	456	-9,639
3	Profit/(loss) for the period	277	-6,030	511	-9,639
4	Profit/(loss) attributable to ordinary equity holders of the parent	370	-5,239	724	-8,848
5	Basic earnings/(loss) per share (Subunit)	0.35	-4.99	0.69	-8.43
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	-0.2300		-0.2400

icy97

生物科学崛起新大股东

财经新闻 财经  2015-01-24 11:11
（吉隆坡23日讯）PN17公司生物科学（BIOSIS，7193，主板消费产品股）宣布，韩查鲁哈兹米尔收购公司1000万股或9.52%股权，崛起为新的大股东。

根据文告，他是在上周五通过场外交易，收购该批股权。

收购股权后，他的持股率超越朝圣基金局（Lembaga Tabung Haji）的8.69%，成为公司第三大股东。

目前，生物科学最大股东为阿兹兹尔万，持有19.05%股权。【南洋网财经】

Notice of Interest Sub. S-hldr (29A)

BIOSIS GROUP BERHAD

Particulars of Substantial Securities Holder

Name	Hamzarul Hazmir Hamdan
Address	No. 7, Laluan Taman Meru 33 Taman Meru 2B (Meru Hills) 30020 Ipoh, Perak
NRIC/Passport No/Company No.	760427-07-5725
Nationality/Country of incorporation	Malaysian
Descriptions (Class & nominal value)	Ordinary shares of RM0.50 each
Name & address of registered holder	Hamzarul Hazmir Hamdan No. 7, Laluan Taman Meru 33 Taman Meru 2B (Meru Hills) 30020 Ipoh, Perak

Date interest acquired & no of securities acquired
Currency	Malaysian Ringgit (MYR)
Date interest acquired	16/01/2015
No of securities	10,000,000
Circumstances by reason of which Securities Holder has interest	Off market transaction
Nature of interest	Direct
Price Transacted ($$)
Total no of securities after change
Direct (units)	10,000,000
Direct (%)	9.52
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Date of notice	22/01/2015

icy97

Date of change	13/02/2015
Name	Khairul Azwan bin Harun
Age	38
Nationality	Malaysian
Type of change	Redesignation
Previous Position	Deputy Chairman
New Position	Chairman
Directorate	Non Independent & Non Executive
Qualifications	1. Bachelor Degree in Accounting from Cardiff University of Wales, United Kingdom 2. Master Degree in Strategic Management from the Open University Malaysia, Kuala Lumpur
Working experience and occupation	Khairul Azwan Harun started his career in 1999 with Ernst & Young, Chartered Accountants at Kuala Lumpur Office and held senior positions in Business Assurance and Corporate Recovery divisions. He was involved in E&Y corporate advisory assignments at several public listed companies and GLCs. He joined Perak State Government in 2004 and was appointed as CEO of Yayasan Bina Upaya Darul Ridzuan (YBUDR), a state charity foundation in 2010 until 2011. Presently, he is the Deputy Chairman of the Board of YBUDR. He is also an adjunct Lecturer of Management and Leadership at Universiti Teknologi Petronas.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/12/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/12/2014	31/12/2013	31/12/2014	31/12/2013
		$$'000	$$'000	$$'000	$$'000

1	Revenue	3,049	2,809	9,333	6,204
2	Profit/(loss) before tax	-236	-18,611	220	-28,250
3	Profit/(loss) for the period	-236	-17,888	207	-27,527
4	Profit/(loss) attributable to ordinary equity holders of the parent	-111	-17,371	613	-26,219
5	Basic earnings/(loss) per share (Subunit)	-0.11	-16.54	0.58	-24.97
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	-0.2300		-0.2400

icy97

Type	Announcement
Subject	MEMORANDUM OF UNDERSTANDING
Description	BIOSIS GROUP BERHAD (“BIOSIS" OR "THE COMPANY") - Memorandum of Understanding (“MOU”) with Forest Secret Sdn Bhd (“FSSB”)
The Board of Directors of Biosis Group Berhad (“BIOSIS”) is pleased to announce that BIOSIS has on 17 February 2015 entered into a Memorandum of Understanding ("MOU") with Forest Secret Sdn Bhd (757713-X) (“FSSB") for the supply and delivery of halal herbal based products (“the Products”) to FSSB (‘the Proposed Supply”). Please refer to the attachment for further details on the MOU. This announcement is dated 17 February 2015. http://www.bursamalaysia.com/market/listed-companies/company-announcements/1879457

Attachments MoU with FSSB 17 Feb 15.pdf

icy97

Name	KHAIRUL AZWAN BIN HARUN
Address	Lot 743, Kampung Tersusun Balun Bidai 36800 Kampong Gajah Perak
Descriptions(Class & nominal value)	Ordinary shares of RM0.50 each

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction	Date of change	No of securities	Price Transacted (RM)
Acquired	30/03/2015	2,000,000	0.250

Circumstances by reason of which change has occurred	Shares purchased by cross deal transaction
Nature of interest	Direct
Consideration (if any)

Total no of securities after change
Direct (units)	2,000,000
Direct (%)	1.9048
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Date of notice	31/03/2015

icy97

Date of change	01/04/2015
Name	MOHAMED NIZA BIN DATO’ HJ ABU BAKAR
Age	40
Nationality	Malaysian
Type of change	Appointment
Designation	Chief Financial Officer
Qualifications	He obtained his degree Bachelor of Arts in Accountancy Studies(Honours) from University of Portsmouth, United Kingdom in 1998.
Working experience and occupation	He has extensive experience in the financial, accounting and corporate advisory sectors having worked in a few entities including company listed on Bursa Malaysia Securities Berhad and Bank Negara Malaysia (statutory body). He was also a CEO of a Self Regulatory Organisation and also an entity with manufacturing outfit.